{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:33:59Z","timestamp":1761557639540,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.sapharm.2022.11.013","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T03:54:20Z","timestamp":1669953260000},"page":"610-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-1354","authenticated-orcid":false,"given":"Grace E.","family":"LaFleur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Azzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7595-4410","authenticated-orcid":false,"given":"Mitchell S.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2022","series-title":"COVID Data Tracker","key":"10.1016\/j.sapharm.2022.11.013_bib1"},{"key":"10.1016\/j.sapharm.2022.11.013_bib2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.15585\/mmwr.mm7044e2","article-title":"The advisory committee on immunization practices' interim recommendations for additional primary and booster doses of COVID-19 vaccines \u2014 United States, 2021","volume":"70","author":"Mbaeyi","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2022.11.013_bib3","doi-asserted-by":"crossref","unstructured":"Golob J. Immunocompromised People Make up Nearly Half of COVID-19 Breakthrough Hospitalizations. Health & Wellness Topics, Health Tips & Disease Prevention. Published August 23, 2021. Accessed March 30, 2022.","DOI":"10.64628\/AAI.yydnqsdxc"},{"key":"10.1016\/j.sapharm.2022.11.013_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15585\/mmwr.mm7104a2","article-title":"Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults \u2013 United States","volume":"71","author":"Tenforde","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"author":"Kotton","key":"10.1016\/j.sapharm.2022.11.013_bib5"},{"issue":"24","key":"10.1016\/j.sapharm.2022.11.013_bib6","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1016\/j.vaccine.2020.02.040","article-title":"Increasing adult vaccinations at a regional supermarket chain pharmacy: a multi-site demonstration project","volume":"38","author":"Coley","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.sapharm.2022.11.013_bib7","first-page":"S51","article-title":"Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy","volume":"vol. 60","author":"Page","year":"2020"},{"key":"10.1016\/j.sapharm.2022.11.013_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10067-019-04841-6","article-title":"A quality improvement intervention failed to significantly increase pneumococcal and influenza vaccination rates in immunosuppressed inflammatory arthritis patients","volume":"39","author":"Murray","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.sapharm.2022.11.013_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10900-017-0421-9","article-title":"Evaluation of pharmacist-initiated interventions on vaccination rates in patients with asthma or COPD","volume":"43","author":"Klassing","year":"2018","journal-title":"J Community Health"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741122004156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741122004156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:29:38Z","timestamp":1761557378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741122004156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1551741122004156"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2022.11.013","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2022.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}